Viewing Study NCT01963702


Ignite Creation Date: 2025-12-25 @ 3:38 AM
Ignite Modification Date: 2026-03-03 @ 3:53 PM
Study NCT ID: NCT01963702
Status: UNKNOWN
Last Update Posted: 2013-10-16
First Post: 2013-10-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase II Trial of Exploring the Predictive Factors of TX and XELOX Regimen in the First Line Treatment of MGC
Sponsor: Fudan University
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Gastric Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None predictive factor View
None response View
None gastric neoplasm View
None oxaliplatin View
None docetaxol View
None capecitabine View